Adjuvant effect of DEAE-Dextran and tetanus toxoid on whole cell heat inactivated phenol preserved typhoid vaccine

Indian Journal of Pathology and Microbiology

Volumn 39, Issue 4, 1996, Pages 287-292

  Kaistha, Jyoti ^a   Sokhey, J ^a   Singh, S ^a   Kumar, S ^a   John, P C ^a   Sharma, N C ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Adjuvant effect; Antibody response; DEAE dextran; Tetanus toxoid; Typhoid vaccine

Indexed keywords

DIETHYLAMINOETHYLDEXTRAN; TETANUS TOXOID; TYPHOID VACCINE;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; MALE; MOUSE; NONHUMAN;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; DEAE-DEXTRAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; MALE; MICE; MICE, INBRED STRAINS; TETANUS TOXOID; TYPHOID-PARATYPHOID VACCINES; VACCINES, INACTIVATED;

EID: 0030457699     PISSN: 03774929     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Edelman R, Levine MM: Summary of an International workshop on typhoid fever. Rev Infect Dis 8: 329-349, 1986.
2. Balaraj V, Sridharan G, Jesudason MV: Immunization against typhoid fever. Natnl Med J India 5 : 12-17, 1992.
3. Bhattacharya SK, Bhattacharya MK, Rasaily R, Deb BC: Treatment of Multiresistant typhoid fever. ICMR Bull 23 : 67-70, 1993.
4. Whittmann G, Dietzschold B, Bauer K: Some investigations of the adjuvant mechanism of DEAE-Dextran. Arch Virol 47 : 225-235, 1975.
5. Houston WE, Crabbs CL, Kremer RJ, Springer JV: Adjuvant effect of diethylaminoethyl dextran. Infect Immun 13 : 1559-1562, 1976.
6. Joo I, Emod J: Adjuvant effect of DEAE-dextran on cholera vaccines. Vaccine 6 : 233-237, 1988.
7. Barr M, Sayers MHP, Stamm WP: Intradermal T.A.B.T. vaccine for immunization against enteric. Lancet 1 : 816-817, 1959.
8. Knox JDE, Stamm WP: Morbidity from TABT inoculations in RAF recruits. Brit Med J 2: 1462, 1957.
9. WHO Technical Report Series: Requirements for typhoid Vaccine. No. 361 (Annex. 4) : 61-75, 1967.
10. United States Code of Federal Regulations: Title 21 : Food and Drugs, Par. 620.10. Typhoid Vaccine. Par. 620.13. Potency test. Washington, D.C. : U.S. Government Printing Office. 58-60, 1980.
11. Reed LJ, Muench H: A simple method of estimating fifty percent endpoints. Am J Hyg 27 : 493-497, 1938.
12. 50 of fifty percent end point. Proc Soc Natl Acad Sci, USA 29 : 207-212, 1943.
13. 50 and its error means of logrithemic probit graph paper. Proc Soc Exp Biol Med 52 : 260-264, 1944.
14. Batson HC: An introduction to statistics in the medical science. Burgess Publishing Co. 16, 1959.
15. Jyoti Kaistha : Efficacy of whole cell typhoid vaccine when used in conjunction with tetanus toxoid and DEAE-dextran. (Dissertation) Shimla, India: Himachal Pradesh University : 57, 1994.
16. Xu HR, Hsu HS, Moncure CW, King RA: Correlation of antibody titres induced by vaccination with protection in mouse typhoid. Vaccine 11 : 725-729, 1993.